NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,090,437 | +28.2% | 1,416,714 | +19.4% | 0.00% | 0.0% |
| Q3 2022 | $10,213,303 | +17.5% | 1,186,214 | +11.2% | 0.00% | +50.0% |
| Q2 2022 | $8,690,321 | -12.7% | 1,066,297 | +30.1% | 0.00% | 0.0% |
| Q1 2022 | $9,954,920 | -64.4% | 819,335 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $27,956,000 | -24.6% | 819,335 | +6.6% | 0.01% | -25.0% |
| Q3 2021 | $37,091,000 | +1.5% | 768,878 | -5.0% | 0.01% | 0.0% |
| Q2 2021 | $36,555,000 | -16.9% | 809,280 | -11.2% | 0.01% | -20.0% |
| Q1 2021 | $43,977,000 | -13.4% | 911,813 | -3.4% | 0.01% | -16.7% |
| Q4 2020 | $50,808,000 | +57.7% | 943,690 | +8.0% | 0.01% | +33.3% |
| Q3 2020 | $32,228,000 | +23.7% | 873,626 | +3.9% | 0.01% | +12.5% |
| Q2 2020 | $26,059,000 | +7.3% | 841,140 | -4.3% | 0.01% | -11.1% |
| Q1 2020 | $24,276,000 | -1.7% | 879,259 | +4.2% | 0.01% | +28.6% |
| Q4 2019 | $24,693,000 | +310.0% | 844,190 | +168.0% | 0.01% | +250.0% |
| Q3 2019 | $6,022,000 | – | 314,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
| PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
| First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
| Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
| Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
| EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
| Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
| Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
| Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |